Coverage
-
July 09, 2018
The U.S. Securities and Exchange Commission has renewed its demand for more than $1 million from a onetime biotech chief executive, telling a New Jersey federal court that his attorney confirmed he pocketed illicit proceeds from the sale of company stock.
2 other articles on this case.
View all »